Xtalks’ Post

View organization page for Xtalks, graphic

9,310 followers

Eli Lilly and Company is finally entering the #Alzheimer’s arena with the FDA approval of its anti-amyloid therapy #Kisunla. Read more about the drug, which will be going up against Biogen and Eisai’s Leqembi: https://buff.ly/3LaoUKj #FDAApproval #AlzheimersDisease #NeurodegenerativeDiseases #BetaAmyloid #AmyloidBeta #AntiAmyloidTherapy #MonoclonalAntibody #EliLilly #Neuroscience #Neurology

Eli Lilly's Kisunla (donanemab) Gets Full FDA Approval After Initial Rejection, Gears Up to Take on Leqembi

Eli Lilly's Kisunla (donanemab) Gets Full FDA Approval After Initial Rejection, Gears Up to Take on Leqembi

xtalks.com

To view or add a comment, sign in

Explore topics